Bionomics (BNOX)
(Delayed Data from NSDQ)
$0.28 USD
+0.01 (3.63%)
Updated Oct 11, 2024 03:58 PM ET
After-Market: $0.29 +0.01 (3.61%) 5:14 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Bionomics Limited Unsponsored ADR (BNOX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.00 | $8.00 | $4.00 | 2,122.22% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Bionomics Limited Unsponsored ADR comes to $6.00. The forecasts range from a low of $4.00 to a high of $8.00. The average price target represents an increase of 2% from the last closing price of $0.27.
Analyst Price Targets (2 )
Broker Rating
Bionomics Limited Unsponsored ADR currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/31/2024 | William Blair | Myles R Minter | Strong Buy | Strong Buy |
7/18/2024 | H.C. Wainwright & Co. | Joseph Pantginis | Strong Buy | Strong Buy |
3/28/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 3 |
Average Target Price | $6.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 85 of 252 |
Current Quarter EPS Est: | NA |
BNOX FAQs
Bionomics Limited Unsponsored ADR (BNOX) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for Bionomics Limited Unsponsored ADR (BNOX) is $6.00. The current on short-term price targets is based on 1 reports.
The forecasts for Bionomics Limited Unsponsored ADR (BNOX) range from a low of $4 to a high of $8. The average price target represents a increase of $2122.22 from the last closing price of $.27.
The current UPSIDE for Bionomics Limited Unsponsored ADR (BNOX) is 2122.22%
Based on short-term price targets offered by two analysts, the average price target for Bionomics Limited Unsponsored ADR comes to $6.00. The forecasts range from a low of $4.00 to a high of $8.00. The average price target represents an increase of 2% from the last closing price of $0.27.